Drug Price Watchdog Making Unfair Decisions, Says Indian Industry Lobby
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - The Indian Drug Manufacturers Association - the largest drug industry body in the country - has lodged a protest with India's department of pharmaceuticals over what the association calls unfair decisions made by the National Pharmaceutical Pricing Authority with regard to pricing of medicines
You may also be interested in...
Spurious Drugs Issue: Indian Government Proposes Cash Rewards For Informers; Industry Supportive
NEW DELHI - Grappling with increasing incidents of spurious drugs, the Indian health ministry has proposed an incentive scheme for "whistle blowers" who provide credible information and help the government in confiscating fake drugs, cosmetics or medical devices
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).